Fragasso Financial Advisors Inc

Position in GILD — Gilead Sciences, Inc.

CIK 1613331 SEWICKLEY, PA

Position in GILD

as of Jun 30, 2026 · filed Jul 9, 2026 Compact

Position Value

$377,630

-$17,344 QoQ

Shares Held

2,989

+5.5% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.09%

of 13F equity value

Holder Rank

#1,532

of 2,266 holders

Holding Since

Mar 2020

14 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Fragasso Financial Advisors Inc holds $24,423,418 across 9 Drug Manufacturers - General names. GILD ranks #7 (1.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson	25,026	$6,355,853
2	LLY	ELI LILLY & Co	4,609	$5,528,173
3	ABBV	AbbVie Inc.	21,001	$5,284,691
4	AMGN	Amgen Inc	11,714	$4,241,873
5	MRK	Merck & Co., Inc.	12,421	$1,596,098
6	PFE	Pfizer Inc	22,006	$529,904
7	GILD	Gilead Sciences, Inc. This page	2,989	$377,630
8	BMY	Bristol Myers Squibb Co	4,605	$265,340

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$377,630	2,989	+5.5%	Shares	Sole	2026-07-09
2026-03-31	$394,974	2,834	+22.9%	Shares	Sole	2026-04-07
2025-12-31	$283,038	2,306	+6.8%	Shares	Sole	2026-01-07
2025-09-30	$239,760	2,160	-0.1%	Shares	Sole	2025-10-06
2025-06-30	$239,811	2,163	+16.3%	Shares	Sole	2025-07-09
2025-03-31	$208,413	1,860	-41.1%	Shares	Sole	2025-04-09
2024-06-30	$216,807	3,160	-6.3%	Shares	Sole	2024-07-09
2024-03-31	$246,925	3,371	+3.2%	Shares	Sole	2024-04-10
2023-12-31	$264,578	3,266	+12.4%	Shares	Sole	2024-01-08
2023-09-30	$217,700	2,905	-3.5%	Shares	Sole	2023-12-06
2023-06-30	$231,980	3,010	+3.9%	Shares	Sole	2023-07-10
2023-03-31	$240,281	2,896	+10.7%	Shares	Sole	2023-04-13
2022-12-31	$224,497	2,615	-43.3%	Shares	Sole	2023-01-24
2020-03-31	$344,793	4,612	—	Shares	Sole	2020-05-14
No filing history on record for this holder in this stock.